Era of COVID-19 in Multiple Sclerosis Care

The unprecedented scope of the coronavirus disease 2019 (COVID-19) pandemic resulted in numerous disruptions to daily life, including for people with multiple sclerosis (PwMS). In this article, we review how disruptions in MS care prompted innovations in delivery of care (e.g., via telemedicine) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Krett, Jonathan D., Salter, Amber, Newsome, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288315/
https://www.ncbi.nlm.nih.gov/pubmed/37980121
http://dx.doi.org/10.1016/j.ncl.2023.06.006
_version_ 1785062058919723008
author Krett, Jonathan D.
Salter, Amber
Newsome, Scott D.
author_facet Krett, Jonathan D.
Salter, Amber
Newsome, Scott D.
author_sort Krett, Jonathan D.
collection PubMed
description The unprecedented scope of the coronavirus disease 2019 (COVID-19) pandemic resulted in numerous disruptions to daily life, including for people with multiple sclerosis (PwMS). In this article, we review how disruptions in MS care prompted innovations in delivery of care (e.g., via telemedicine) and mobilized the global MS community to rapidly adopt safe and effective practices. We discuss how our understanding of the risks of COVID-19 in PwMS has evolved along with recommendations pertaining to disease-modifying therapies (DMTs) and vaccines. With lessons learned during the COVID-19 pandemic, we examine potential questions for future research in this new era of MS care.
format Online
Article
Text
id pubmed-10288315
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-102883152023-06-23 Era of COVID-19 in Multiple Sclerosis Care Krett, Jonathan D. Salter, Amber Newsome, Scott D. Neurol Clin Article The unprecedented scope of the coronavirus disease 2019 (COVID-19) pandemic resulted in numerous disruptions to daily life, including for people with multiple sclerosis (PwMS). In this article, we review how disruptions in MS care prompted innovations in delivery of care (e.g., via telemedicine) and mobilized the global MS community to rapidly adopt safe and effective practices. We discuss how our understanding of the risks of COVID-19 in PwMS has evolved along with recommendations pertaining to disease-modifying therapies (DMTs) and vaccines. With lessons learned during the COVID-19 pandemic, we examine potential questions for future research in this new era of MS care. Elsevier Inc. 2023-06-23 /pmc/articles/PMC10288315/ /pubmed/37980121 http://dx.doi.org/10.1016/j.ncl.2023.06.006 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Krett, Jonathan D.
Salter, Amber
Newsome, Scott D.
Era of COVID-19 in Multiple Sclerosis Care
title Era of COVID-19 in Multiple Sclerosis Care
title_full Era of COVID-19 in Multiple Sclerosis Care
title_fullStr Era of COVID-19 in Multiple Sclerosis Care
title_full_unstemmed Era of COVID-19 in Multiple Sclerosis Care
title_short Era of COVID-19 in Multiple Sclerosis Care
title_sort era of covid-19 in multiple sclerosis care
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288315/
https://www.ncbi.nlm.nih.gov/pubmed/37980121
http://dx.doi.org/10.1016/j.ncl.2023.06.006
work_keys_str_mv AT krettjonathand eraofcovid19inmultiplesclerosiscare
AT salteramber eraofcovid19inmultiplesclerosiscare
AT newsomescottd eraofcovid19inmultiplesclerosiscare

Ejemplares similares